4.6 Article

Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for Binding

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies

Frank M. P. van Haren et al.

Summary: There is significant interest in using nebulised unfractionated heparin as a therapy for COVID-19 patients with acute hypoxaemic respiratory failure. Nebulised heparin may prevent blood clot formation in the lungs and directly inactivate the SARS-CoV-2 virus. The CHARTER-MT meta-trial aims to examine the effects of inhaled heparin on various endpoints in COVID-19 patients requiring invasive ventilation.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Infectious Diseases

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

Michela Antonelli et al.

Summary: Despite the high efficacy of COVID-19 vaccines, some individuals still become infected with SARS-CoV-2 post-vaccination. Risk factors for post-vaccination infection include frailty in older adults, living in deprived areas, and obesity. Vaccination is associated with reduced odds of severe symptoms and long-duration illness. The findings suggest the importance of targeting at-risk populations and maintaining infection control measures even in vaccinated individuals.

LANCET INFECTIOUS DISEASES (2022)

Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Medicine, General & Internal

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

Christopher T. Rentsch et al.

Summary: The study found that early initiation of prophylactic anticoagulation was associated with decreased risk of 30 day mortality among patients hospitalized with covid-19 in the United States, without increasing the risk of serious bleeding events.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Hematology

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Adam Cuker et al.

Summary: The American Society of Hematology provided two conditional recommendations for anticoagulation in COVID-19-related critical illness and acute illness, emphasizing the low certainty in the evidence and the importance of future high-quality randomized controlled trials for validation.

BLOOD ADVANCES (2021)

Article Chemistry, Multidisciplinary

Polysulfates Block SARS-CoV-2 Uptake through Electrostatic Interactions**

Chuanxiong Nie et al.

Summary: The study demonstrates that highly sulfated linear polyglycerol sulfate (LPGS) is an optimal inhibitor for SARS-CoV-2, showing more than 60-fold higher virus inhibitory activity than heparin with lower anticoagulant activity. Molecular dynamics simulations confirm that LPGS binds more strongly to the spike protein of the virus and interacts more with new variants, suggesting it can serve as a blueprint for designing novel viral inhibitors.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Multidisciplinary

A Rapid and Mild Sulfation Strategy Reveals Conformational Preferences in Therapeutically Relevant Sulfated Xylooligosaccharides

Yen Vo et al.

Summary: This study describes the synthesis of the largest homogeneous persulfated xylooligomers, up to eight xylose residues, as standards for biological studies. Near quantitative sulfation was achieved using a mild and simple protocol, allowing definitive identification of impurities in a commercially prepared Pentosan drug.

CHEMISTRY-A EUROPEAN JOURNAL (2021)

Article Biochemistry & Molecular Biology

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template

Calvin J. Gordon et al.

Summary: The study found that Molnupiravir or NHC can increase the mutation frequencies in replicating coronaviruses, leading to enhanced antiviral effects; NHC-TP primarily competes with CTP for incorporation, resulting in RNA mutations; Biochemical data support a mechanism of action of Molnupiravir that is primarily based on RNA mutagenesis mediated via the template strand.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Review Hematology

Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis

Roberta Parisi et al.

Summary: A systematic review and meta-analysis on the association of anticoagulant use and in-hospital mortality in COVID-19 patients revealed a 50% reduction in mortality risk with anticoagulant use, especially in ICU patients. However, therapeutic anticoagulant regimens were associated with higher bleeding risks. Therefore, prophylactic dosages of anticoagulants may be preferred in noncritically ill patients.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

Article Biochemistry & Molecular Biology

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

Florian Kabinger et al.

Summary: Molnupiravir is an oral antiviral drug candidate that increases viral RNA mutations frequency and inhibits replication of SARS-CoV-2 by altering the substrate preference of RdRp. This two-step mutagenesis mechanism can explain the broad-spectrum antiviral activity of molnupiravir, making it a promising COVID-19 treatment option.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Article Immunology

Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study

Janak Koirala et al.

Summary: This study evaluated the safety and outcomes of convalescent plasma therapy and/or remdesivir treatment in 1315 hospitalized COVID-19 patients in Nepal. Most convalescent plasma therapy recipients had severe to life-threatening infections, while remdesivir recipients had less severe infection and better outcomes.

OPEN FORUM INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain

Zachariah P. Schuurs et al.

Summary: A new GAG binding site was identified in the spike protein, which may be crucial for understanding recent UK and South African strains. These findings could also aid in future targeted therapy programs.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Virology

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

Ritesh Tandon et al.

Summary: SARS-CoV-2 virus relies on spike glycoprotein for cell entry, and several sulfated polysaccharides have shown potent neutralizing effects against the virus, demonstrating potential prophylactic and therapeutic applications.

JOURNAL OF VIROLOGY (2021)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Cell Biology

Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro

Paul S. Kwon et al.

CELL DISCOVERY (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Thomas Mandel Clausen et al.

Article Chemistry, Analytical

Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins

Lucio Mauri et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)

Article Pharmacology & Pharmacy

Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells

Silvia Ghezzi et al.

ANTIVIRAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Inhibition of influenza H5N1 invasion by modified heparin derivatives

Mark A. Skidmore et al.

MEDCHEMCOMM (2015)

Article Biochemistry & Molecular Biology

Antithrombin stabilisation by sulfated carbohydrates correlates with anticoagulant activity

Marcelo A. Lima et al.

MEDCHEMCOMM (2013)

Review Hematology

Contaminants in Heparin: Review of the Literature, Molecular Profiling, and Clinical Implications

Eduardo Ramacciotti et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2011)

Article Multidisciplinary Sciences

Orthogonal analytical approaches to detect potential contaminants in heparin

Marco Guerrini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Urology & Nephrology

Molecular size affects urine excretion of pentosan polysulfate

DR Erickson et al.

JOURNAL OF UROLOGY (2006)

Article Pharmacology & Pharmacy

Metabolism of [3H]pentosan polysulfate sodium (PPS) in healthy human volunteers

M Simon et al.

XENOBIOTICA (2005)

Review Biotechnology & Applied Microbiology

Inhibitors of virus replication:: recent developments and prospects

J Magden et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)

Article Immunology

Coronaviridae and SARS-associated coronavirus strain HSR1

E Vicenzi et al.

EMERGING INFECTIOUS DISEASES (2004)